One acquisition solution for integrated services plus (OASIS+) unrestricted multiple agency contract (MAC)
Active Awarded Last action
- Contract number
- 47QRCA25DU681
- Awardee
-
SIA Partners U.s., Inc. UEI M7H6L5MK9MN8
- Awarding agency
-
Federal Acquisition Service
General Services Administration
- Task orders
- 0
Award facts
- Opportunity
-
- GSA’s OASIS+ MAC Draft Request for Proposal #2 Pre-Solicitation · 47QRCA23R0006 · Posted Mar 2, 2021
- Last date to order 30% complete
- IDV ceiling
- $999,999,999,999.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 766 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Federal Acquisition Service awarded an indefinite-delivery contract to SIA Partners U.S., Inc. (doing business as Latham Biopharm Group) on April 15, 2025, under the OASIS+ Unrestricted multiple-award program, with a contract ceiling of $999,999,999,999.00 and an ultimate completion date of April 14, 2030. This is a multiple-award vehicle carrying no set-aside restriction.
The originating solicitation, posted March 2, 2021, with a due date of March 29, 2023, sought integrated services across the federal government. Place of performance follows standard OASIS+ Unrestricted geographic scope, enabling work nationwide and worldwide as task orders direct.
SIA Partners U.S., Inc., operating as Latham Biopharm Group, is a life science consulting firm specializing in advanced scientific and consulting services to federal agencies in the pharmaceutical and biotechnology sectors, with expertise in infectious disease therapeutics, preclinical services, and research support. The company has supported programs at the National Institutes of Health, Department of Defense, and other federal research entities, delivering medicinal chemistry support, preclinical services, analytical assay development, and regulatory activities in support of therapeutic and diagnostic development.
The contract is one of multiple awards under the OASIS+ Unrestricted program, which provides federal agencies with a consolidated source for professional services and advanced technical solutions across civilian and defense missions.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,500 |
Quick answers
Who was awarded contract 47QRCA25DU681?
47QRCA25DU681 was awarded to SIA Partners U.s., Inc. by Federal Acquisition Service (General Services Administration) on April 15, 2025.
How much is contract 47QRCA25DU681 worth?
47QRCA25DU681's own ceiling is $999,999,999,999.
Who can order from contract 47QRCA25DU681?
47QRCA25DU681 is a multiple award indefinite delivery contract. All agencies can place orders on it.
Is contract 47QRCA25DU681 part of a contract vehicle?
Yes. 47QRCA25DU681 is part of One Acquisition Solution for Integrated Services Plus - Unrestricted (OASIS+ Unrestricted).
Was contract 47QRCA25DU681 competed?
The extent of competition for 47QRCA25DU681 was full and open competition. The government received 766 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV